Full Alliance Group, Inc. (FAGI)
OTCMKTS · Delayed Price · Currency is USD
0.0588
-0.0060 (-9.26%)
Jan 20, 2026, 3:41 PM EST
Full Alliance Group Market Cap
Full Alliance Group has a market cap or net worth of $8.38 million as of January 20, 2026. Its market cap has increased by 583.62% in one year.
Market Cap
8.38M
Enterprise Value
n/a
Revenue
82.12K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since September 6, 2005, Full Alliance Group's market cap has increased from 4.62M to 8.38M, an increase of 81.42%. That is a compound annual growth rate of 2.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 8.39M | -4.45% |
| Dec 31, 2025 | 8.78M | 443.62% |
| Dec 31, 2024 | 1.62M | 54.26% |
| Dec 28, 2023 | 1.05M | 67.64% |
| Dec 30, 2022 | 624.71K | -43.26% |
| Dec 31, 2021 | 1.10M | 12.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |